Thistle Mary

Thistle Mary is listed in filings as Director at Vigil Neuroscience, Inc.. This profile follows SEC Form 4 activity through Oct 27, 2025, including 10 public disclosures. Recent filings connect the profile to Vigil Neuroscience, Inc. (VIGL), Entrada Therapeutics, Inc. (TRDA), Q32 Bio Inc. (QTTB), and Cullinan Therapeutics, Inc. (CGEM). The current snapshot covers public activity from Jun 14, 2024 to Oct 27, 2025. Reported amounts are shown as $40.0K to $61.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.